Laborate Pharmaceuticals Sets Ambitious Goal to Double Its Scale Within Five Years
Arpit Bhatia, Director of Laborate Pharmaceuticals, discusses the company’s forward-looking strategies to broaden its therapeutic portfolio, strengthen global competitiveness, and embrace digital transformation across its operations. He also sheds light on the vision behind Aqualab, Laborate’s new direct-to-retail (D2R) division.
Laborate Pharmaceuticals | 09/10/2025
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy